Investor Relations

A coordination layer for healthcare's most valuable relationships

KOLX turns scattered KOL activity into a two-sided relationship-intelligence network — governed, measurable, and built for the medical affairs and commercial teams of pharma. Review the full investor briefing below.

32 slides7 chaptersQ2 2026 edition
kolx.io/investors — KOLX Investor Briefing
Open

The thesis at a glance

Why KOLX, why now

A two-sided network

Enterprises run the organization from one role-aware command center; experts opt in through a portal they actually want to use. Value compounds on both sides.

Compliance in the workflow

Engagements move on rails with traceable action, RBAC, and audit built in — not bolted on. Formal SOX-controls readiness is on the roadmap.

The intelligence layer

Enrichment and health scoring turn every interaction into relationship intelligence and influence signal that no incumbent tool captures today.

Inside the briefing

What you'll find in the deck

A 32-slide walkthrough of the problem, the platform, the network effect, and the opportunity — plus a technical appendix on architecture, governance, and controls.

View the briefing
  1. 01Executive summary
  2. 02Why now · market context
  3. 03The problem & root causes
  4. 04The platform
  1. 05The two-sided network
  2. 06Value, differentiation & roadmap
  3. 07The opportunity
  4. AAppendix · architecture, security & SOX

Let's talk about the opportunity

For diligence materials, financials, or a live walkthrough with the founding team, get in touch.